OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
March 13, 2019
Norman (Ned) Sharpless, director of the National Cancer Institute at the National Institutes of Health, will become FDA acting commissioner.
The FDA planned budget features added funds allotted to improved oversight of drugs, biologics, and medical devices.
March 06, 2019
Gottlieb’s tenure included record new drug approvals and steps taken to curb opioid abuse.
March 02, 2019
FDA expects more than 200 investigational new drug applications for cell and gene therapies by 2020, causing the agency to strengthen its regulatory program.
February 20, 2019
The agency clarified the process for development programs for regenerative medicine therapies.
February 15, 2019
FDA came away with the largest boost in its annual budget in a decade as part of the final spending package approved by Congress this week.